Cell Bio Human Tech Co Ltd

Cell Bio Human Tech Co Ltd maintains a strong capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 3.42, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which could signal potential liquidity constraints.

In terms of profitability, the company's return on equity (ROE) is 1.44%, and its return on assets (ROA) is 1.22%. These figures are below the typical thresholds for strong performance in the Textiles & Leather Goods industry, indicating that the company may not be generating returns as efficiently as its peers.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risks if demand in its primary market fluctuates.

Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth projections are provided in the available data. However, the company's operating cash flow of 2,865,339,960 KRW and free cash flow of 1,024,776,700 KRW suggest it has the ability to fund operations and potentially invest in future growth.

The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The risk assessment highlights that the company's net cash is negative after subtracting total debt, which could affect its ability to meet short-term obligations. No significant dilution sources are identified in the available data, and the company's capital structure does not indicate near-term pressure for additional equity issuance.

Recent financial filings and transcripts do not provide specific details on new product launches, strategic partnerships, or other material events that could impact the company's performance. The available data is limited to standard financial disclosures.

Revenue surged 79.7% year-over-year to 51.1 billion KRW, demonstrating strong top-line growth momentum.

Net income nearly doubled with a 99.2% year-over-year increase, reaching 8.7 billion KRW in the latest period.

Debt-to-equity ratio of 0.14 is well below the cohort median of 0.43, suggesting a conservative capital structure.

The company faces a high credit risk level, which could impact borrowing costs and financial stability.

Medium liquidity risk flags suggest potential challenges in meeting short-term financial obligations promptly.

Long-term debt increased significantly to 20.5 billion KRW, raising concerns about future debt servicing obligations.